HAE vs. ON
HAE (Haemonetics Corporation) and ON (ON Semiconductor Corporation) are both stocks. HAE operates in Medical Instruments & Supplies (Healthcare), while ON operates in Semiconductors (Technology). Over the past 10 years, HAE returned 9.57%/yr vs 26.27%/yr for ON. At a 0.28 correlation, their price movements are largely independent.
Performance
HAE vs. ON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HAE achieves a -4.94% return, which is significantly lower than ON's 77.21% return. Over the past 10 years, HAE has underperformed ON with an annualized return of 9.57%, while ON has yielded a comparatively higher 26.27% annualized return.
HAE
- 1D
- 1.59%
- 1M
- -2.57%
- 6M
- -7.12%
- YTD
- -4.94%
- 1Y
- 0.89%
- 3Y*
- -3.71%
- 5Y*
- 3.72%
- 10Y*
- 9.57%
ON
- 1D
- -1.95%
- 1M
- -17.84%
- 6M
- 54.38%
- YTD
- 77.21%
- 1Y
- 60.66%
- 3Y*
- -0.24%
- 5Y*
- 20.51%
- 10Y*
- 26.27%
HAE vs. ON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HAE Haemonetics Corporation | -4.94% | 2.65% | -8.69% | 8.72% | 48.28% | -55.33% | 3.35% | 14.84% | 72.26% | 44.48% |
ON ON Semiconductor Corporation | 77.21% | -14.12% | -24.52% | 33.93% | -8.17% | 107.52% | 34.25% | 47.67% | -21.16% | 64.11% |
Correlation
The correlation between HAE and ON is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since May 2, 2000 | 0.28 |
The correlation between HAE and ON shifts across timeframes, from 0.08 (1 year) to 0.32 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
HAE:
$3.46B
ON:
$37.35B
HAE:
$2.07
ON:
$1.43
HAE:
36.77
ON:
67.15
HAE:
2.68
ON:
6.35
HAE:
3.94
ON:
5.18
HAE:
$1.33B
ON:
$6.06B
HAE:
$787.59M
ON:
$2.26B
HAE:
$252.91M
ON:
$1.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HAE vs. ON — Risk / Return Rank
HAE
ON
HAE vs. ON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Haemonetics Corporation (HAE) and ON Semiconductor Corporation (ON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HAE | ON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.04 | ||
| Sortino ratioReturn per unit of downside risk | -1.22 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.22 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.06 | 1.82 | -1.88 |
| Martin ratioReturn relative to average drawdown | -0.10 | 3.99 | -4.09 |
Loading charts...
Drawdowns
HAE vs. ON - Drawdown Comparison
The maximum HAE drawdown since its inception was -68.62%, smaller than the maximum ON drawdown of -96.34%. Use the drawdown chart below to compare losses from any high point for HAE and ON.
Loading charts...
Drawdown Indicators
| HAE | ON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.62% | -96.34% | +27.72% |
Max Drawdown (1Y)Largest decline over 1 year | -40.06% | -33.87% | -6.19% |
Max Drawdown (3Y)Largest decline over 3 years | -51.04% | -70.44% | +19.40% |
Max Drawdown (5Y)Largest decline over 5 years | -51.04% | -70.44% | +19.40% |
Max Drawdown (10Y)Largest decline over 10 years | -68.62% | -70.44% | +1.82% |
Current DrawdownCurrent decline from peak | -45.38% | -28.35% | -17.03% |
Average DrawdownAverage peak-to-trough decline | -23.91% | -53.83% | +29.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.93% | 15.38% | +10.55% |
Volatility
HAE vs. ON - Volatility Comparison
The current volatility for Haemonetics Corporation (HAE) is 9.65%, while ON Semiconductor Corporation (ON) has a volatility of 36.54%. This indicates that HAE experiences smaller price fluctuations and is considered to be less risky than ON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HAE | ON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.65% | 36.54% | -26.89% |
Volatility (6M)Calculated over the trailing 6-month period | 28.05% | 52.76% | -24.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.89% | 62.22% | -8.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.99% | 55.19% | -15.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.99% | 51.90% | -11.91% |
Dividends
HAE vs. ON - Dividend Comparison
Neither HAE nor ON has paid dividends to shareholders.
Financials
HAE vs. ON - Financials Comparison
This section allows you to compare key financial metrics between Haemonetics Corporation and ON Semiconductor Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HAE vs. ON - Profitability Comparison
HAE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Haemonetics Corporation reported a gross profit of 209.58M and revenue of 346.35M. Therefore, the gross margin over that period was 60.5%.
ON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, ON Semiconductor Corporation reported a gross profit of 583.10M and revenue of 1.51B. Therefore, the gross margin over that period was 38.5%.
HAE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Haemonetics Corporation reported an operating income of -25.19M and revenue of 346.35M, resulting in an operating margin of -7.3%.
ON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, ON Semiconductor Corporation reported an operating income of -53.40M and revenue of 1.51B, resulting in an operating margin of -3.5%.
HAE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Haemonetics Corporation reported a net income of -20.15M and revenue of 346.35M, resulting in a net margin of -5.8%.
ON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, ON Semiconductor Corporation reported a net income of -33.40M and revenue of 1.51B, resulting in a net margin of -2.2%.
Frequently Asked Questions
HAE and ON have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ON has higher volatility (36.54%) compared to HAE (9.65%). In terms of maximum drawdown, HAE dropped -68.62% vs ON's -96.34%.
ON currently has the higher Sharpe Ratio (0.99 vs -0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HAE and ON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer